Else Nutrition (BABY) Q1 2025 earnings summary

Executive summary

• Implemented a comprehensive transformation strategy focused on operational discipline, market focus, and product innovation to address macro pressures and funding constraints.

• Revenue held steady at $2.1 million for Q1 2025, matching Q1 2024 levels.

• Reduced overhead, restructured roles, and eliminated inefficiencies to lower cash burn and protect core capabilities.

• Shifted manufacturing of powder formulas to Europe to reduce production costs, improve gross margins, and mitigate supply chain risks.

• Expanded U.S. retail presence with Kids Ready-to-Drink Shakes now in 950 Walmart stores.

Financial highlights

• Total revenues for Q1 2025 were $2.1 million, flat year-over-year despite market headwinds.

• Gross profit and margin surged to $0.5 million (25%), up from $0.18 million (8%) in Q1 2024, driven by a 15% reduction in cost of sales.

• Operating expenses dropped nearly 48% to $2.2 million, with employee benefits down 24% and advertising halved.

• Operating loss narrowed by over 58% to $1.7 million from $4 million year-over-year.

• Cash balance at quarter-end: $0.2 million (including restricted cash).

Outlook and guidance

• Plans to operate with a small team into 2026, aiming for cash positivity by late 2026 or early 2027.

• Focus areas include maintaining and growing retail accounts, expanding online sales, adding international distributors, improving gross margins, and expanding the product portfolio.

• Plans to shift powder formula manufacturing to Europe to reduce costs and improve margins.

• Exploring strategic collaborations to accelerate scaling.

• Optimism regarding regulatory progress for plant-based infant formula in the U.S.